Apoptotic vascular endothelial cells become procoagulant

Blood

Volumn 89, Issue 7, 1997, Pages 2429-2442

  Bombeli, Thomas ^a   Karsan, Aly ^a   Tait, Jonathan F ^a   Harlan, John M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROCOAGULANT; PROTEIN KINASE INHIBITOR; STAUROSPORINE; THROMBIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CELL ADHESION; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0030956584     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2429     Document Type: Article

References (60)

1. Esmon CT: Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function of the vessel surface. FASEB J 9:946, 1995
2. Bourin MC, Lindahl U: Glycosaminoglycans and the regulation of blood coagulation. Biochem J 289:313, 1993
3. Broze GJ: The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 29:159, 1992
4. van Heerde IVL, de Groot PG, Reutelingsperger CPM: The complexity of the phospholipid binding protein annexin V. Thromb Haemost 73:172, 1995
5. Martin DMA, Boys CWG, Ruf W: Tissue factor: Molecular recognition and cofactor function. FASEB J 9:852, 1995
6. Nachman RL: Thrombosis and atherogenesis: Molecular connections. Blood 79:1897, 1992
7. Rodgers GM: Hemostatic properties of normal and perturbed vascular cells. FASEB J 2:116, 1988
8. Kockx MM, Gambier BA, Bortier HE, De Meyer GR, Declercq SC, Van Cauwelaert PA, Bultinck J: Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology 25:365, 1994
9. Isner JM, Kearney M, Bortman S, Passeri J: Apoptosis in human atherosclerosis and restenosis. Circulation 91:2703, 1995
10. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G: Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 147:267, 1995
11. Hladovec J, Prerowsky L: Endothelial lesion in hypertension. Cor Vasa 31:51, 1989
12. Hladovec J, Prerowsky L, Stanek V, Fabrian J: Circulating endothelial cells in acute myocardial infarction and angina pectoris. Klin Wochenschr 56:1033, 1978
13. Hladovec J: Experimental homocystinemia, endothelial lesions and thrombosis. Blood Vessels 16:202, 1979
14. Hansson GK, Chao S, Schwartz SM, Reidy MA: Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am J Pathol 121:123, 1985
15. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB: Induction of endothelial cell apoptosis by TNFα: Modulation by inhibitor of protein synthesis. Exp Cell Res 214:584, 1994
16. Buchman TG, Abello PA, Smith EH, Bulkley GB: Induction of heat shock response leads to apoptosis in endothelial cells previously exposed to endotoxin. Am J Physiol 265:H165, 1993
17. Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bornkamm GW, Holler E: Critical involvement of transmembrane tumor necrosis factor-α in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86:4184, 1995
18. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhäusl W: High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44:1323, 1995
19. de Bono DF, Yang WD: Exposure of low concentrations of hydrogen peroxide causes delayed endothelial cell death and inhibits proliferation of surviving cells. Atherosclerosis 114:235, 1995
20. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745, 1973
21. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R: An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization. Proc Natl Acad Sci USA 76:5674, 1979
22. Meredith JE Jr, Fazeli B, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 4:953, 1993
23. Wood BL, Gibson DF, Tait JF: Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical association. Blood 88:1873, 1996
24. Tait JF, Gibson DF, Fujikawa K: Phospholipid binding properties of human placental anticoagulant protein I, a member of the lipocortin family. J Biol Chem 264:7944, 1989
25. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
26. Sandset PM, Larsen ML, Abildgaard U, Lindahl AK, Odegaard OR: Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels in the normal population and relation to cholesterol. Blood Coagul Fibrinolysis 2:425, 1991
27. Lupu C, Lupu F, Dennehy U, Kakkar VV, Scully MF: Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol 15:2055, 1995
28. Bombeli T, Müller M, Straub PW, Haeberli A: Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood. J Lab Clin Med 6:621, 1996
29. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
30. Telford WG, King LE, Fraker PJ: Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 13:137, 1992
31. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207,1992
32. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
33. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphalidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
34. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger CPM: A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells-using fluorescein labelled annexin V. J Immunol Methods 184:39, 1995
35. Rosing J, van Rijn JLML, Bevers EM: The role of activated human platelets in prothrombin and factor X activation. Blood 65:319, 1985
36. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ: Complement proteins G56-9 cause release of membrane vesicles from platelet surface that are enriched in the membrane receptor for factor Va and express prothrombinase activity. J Biol Chem 263:1802, 1988
37. Thiagarajan P, Tait JF: Collagen-induced exposure of anionic phospholipids in platelets and platelet-derived microparticles. J Biol Chem 266:24302, 1991
38. Dittman WA: Thrombomodulin: Biology and potential cardiovascular applications. Trends Cardiovasc Med 1:331, 1991
39. De Agostini AI, Watkins SC, Slayter HS, Youssoufian H, Rosenberg RD: Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: Antithrombin binding to cultured endothelial cells and perfused rat aorta. J Cell Biol 111:1293, 1990
40. Biedermann B, Rosenmund A, Müller M, Kohler HP, Haeberli A, Straub PW: Human endothelial cells suppress prothrombin activation in non-anticoagulated whole blood in vitro. J Lab Clin Med 124:339, 1994
41. Kohler HP, Müller M, Bombeli T, Straub PW, Haeberli A: The suppression of the coagulation of non-anticoagulated whole blood in vitro by human umbilical vein endothelial cells cultivated on microcarriers is not dependent on protein C activation. Thromb Haemost 73:719, 1995
42. Rodgers GM, Greenberg CS, Shuman MA: Characterization of the effects of cultured vascular endothelial cells on the activation of blood coagulation. Blood 61:1155, 1983
43. Suzuki K, Azuma Y, Onishi Y, Kizaki H, Ishimura Y: Biphasic effect of staurosporine on thymocyte apoptosis. Biochem Mol Biol Int 35:1085, 1995
44. Falcieri E, Martelli A, Bareggi R, Cataldi A, Cocco L: The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. Biochem Biophys Res Commun 193:19, 1993
45. Sedlak J, Humakova L, Duraj J, Chorvath B, Novotny C: Effects of protein kinase C inhibitor, staurosporine derivative CGP 41251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines. Anticancer Drugs 6:70, 1995
46. Koh JY, Wie MB, Gwag BJ, Sensi SL, Canzoniero LMT, Demaro J, Csernansky C, Choi DW: Staurosporine-induced neuronal apoptosis. Exp Neurol 135:153, 1995
47. Jacobsen MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365, 1993
48. Brinkman HJM, Mertens K, Holthuis J, Zwart-Huinink LA, Grijm K, Van Mourik JA: The activation of blood coagulation factor X on the surface of endothelial cells: A comparison with various vascular cells, platelets, and monocytes. Br J Hematol 87:332, 1994
49. Aupeix K, Toti F, Satta N, Bischoff P, Freyssinet JM: Oxysterols induce membrane procoagulant activity in monocytic THP-1 cells. Biochem J 314:1027, 1996
50. Lupu F, Moldovan N, Ryan J, Stern D, Simionescu N: Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium. Blood Coagul Fibrinolysis 4:743, 1993
51. Antonov AS, Key NS, Smirnov MD, Jacob HS, Vercellotti GM, Smirnov VN: Prothrombotic phenotype diversity of human endothelial cells in culture. Thromb Res 67:135, 1992
52. Greeno EW, Bach RR, Moldow CF: Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 75:281, 1996.
53. Bach R, Rifkin DB: Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium. Proc Natl Acad Sci USA 87:6995, 1990
54. Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N: Neutrophil apoptosis is associated with a reduction in CD 16 (FcγRIII) expression. J Immunol 153:1254, 1994
55. Malorni W, Rivabene R, Santini MT, Paradisi S, Iosi F, Donelli G: Down-modulation of CD4 antigen during programmed cell death in U937 cells. FEBS Lett 336:335, 1993
56. Bellamy COC, Malcomson RDG, Harrison DJ, Wyllie AH: Cell death in health and disease: The biology and regulation of apoptosis. Semin Cancer Biol 6:3, 1995
57. Lum H, Malik AB: Regulation of vascular endothelial barrier function. Am J Physiol 267:L223, 1994
58. Guidry C: Fibroblast contraction of collagen gels requires activation of protein kinase C. J Cell Physiol 155:358, 1993
59. Yoshimura M, Nishikawa A, Nishiura T, Ihara Y, Kanayama Y, Matsuzawa Y, Taniguchi: Cell spreading in Colo 201 by staurosporine is alpha 3 beta 1 integrin-mediated with tyrosine phosphorylation of Src and tensin. J Biol Chem 270:2298, 1995
60. Casciola-Rosen L, Rosen A, Petri M, Schissel M: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 93:1624, 1996